Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.

Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens. Clin Infect Dis. 2014 Sep 15; 59(6):888-96.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.